HOME >> MEDICINE >> NEWS
Successful Cancer Therapy May Doom Later Treatments To Failure

n where the cells grew. Breast tumors grown in the brain, for example, had blood vessels with much smaller pores than did tumors grown under the skin. Pore size was also greatly reduced in the shrunken hormone-dependent tumors. In fact, withdrawal of testosterone resulted in a reduction of pore size from 200 nanometers (nm) to less than 7 nm within 48 hours in a testosterone-dependent tumor.

"That tells you that you just can't make a drug and expect it to work on all tumors," says Jain. Sue Hobbs and Wayne Monsky, an MD-PhD student and postdoctoral fellow, respectively, in Jain's lab, are lead authors on the paper.

The study casts new light on some old cancer puzzles. For example, some anticancer agents that work well in the petri dish fail to kill cancer cells in the body. The new findings suggest that such candidate drugs may never get a chance to prove their cancer-killing powers because they have been engineered too large for the microscopic doors they have to pass through.

Equally perplexing, some chemotherapies lose their efficacy after only a few rounds. Many have chalked up these failures to the development of resistance -- when successive rounds of chemotherapeutic agents allow impervious mutants to gain a foothold. "You can't talk about multidrug resistance if you can't get the drugs into the tumor," says Jain. He believes there is another explanation for such disappointing results: chemotherapeutic agents may, by shrinking tumors, be shrinking blood vessel pores -- in effect, closing the door behind them.

The implications are that drug makers must not only design agents that get through a variety of microscopic doors, they must also think about aiming their drugs at a moving target -- blood vessel pores that change in size over the course of treatment. Yet drug companies have been taking a one-size-fits-all approach, Jain says. In the area of gene therapy, the trend has been to design bigger and more impressive
'"/>

Contact: Bill Schaller
schaller@hms.harvard.edu
617-432-0441
Harvard Medical School
14-Apr-1998


Page: 1 2 3 4

Related medicine news :

1. Successful therapy for head and neck cancer may lead to long-term circulatory problems
2. Successful, rapid protein crystallization possible with technique developed by UCSD researcher
3. Successful prostate surgery: Its quality of surgery not quantity that matters most
4. Successful implementation of pilot study for HIV antiretroviral therapy in Uganda
5. Successful measles vaccination feasible in low-income countries
6. New Procedure Makes A Successful Transplant Possible
7. Patients Treated Successfully For Hodgkins Disease Are At 9 Times The Risk For Developing Second Cancer
8. Vaccine Against Melanoma Proves Successful For Patients With Disease Spread To Two Lymph Node Areas
9. NHLBI Clinical Trial Stopped Early: Successful Ventilator Strategy Found For Intensive Care Patients On Life Support
10. Magnetic Surgery System Tested Successfully On First Patient
11. Successful Atherosclerosis Treatment Program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... National University has ... American Heart Association (AHA)-San Diego Chapter to raise awareness of heart health. Meb ... Saturday, September 21 in Balboa Park alongside National University System Chancellor and AHA ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... contributing to the long-term health of canines – specifically golden retrievers - through ... Retrievers will die from cancer – one out of five retrievers in the ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... to join the largest accountable care organization (ACO) in the country, the company ... this groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity ...
(Date:9/17/2019)... ... September 17, 2019 , ... Dr. Perry Patel, ... been certified by the American Academy of Facial Esthetics (AAFE) to administer Botox ... range of orofacial conditions such as tooth clenching and grinding, tongue tension, temporomandibular ...
(Date:9/17/2019)... ... September 17, 2019 , ... The ... announce the release of the third edition of The Gift of Participation. Written ... patients, caregivers and families to navigate the clinical research process. The new edition ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Drs. ... and Medford, NJ, now welcome patients from Cherry Hill, NJ for tooth extractions, ... teeth whenever possible. When tooth removal is necessary, they use advanced equipment and ...
(Date:9/17/2019)... ... September 17, 2019 , ... Embr Labs , the ... Series B funding led by DigiTx Partners, with participation from Safar Partners, ... use the investment to grow the company’s footprint in wellness and digital therapeutics, accelerate ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... for employers, became the first commercial teledentistry practice in the United States. Now, ... other hub entrepreneurs, company leaders, innovators and industry experts next week at CIC ...
Breaking Medicine Technology:
Cached News: